JNJ - Johnson & Johnson wins FDA nod for new multiple myeloma therapy
2023-08-10 08:06:33 ET
More on Johnson & Johnson
- Future Prospects For Johnson & Johnson Following Strong Q2 Performance
- Johnson & Johnson: Resilient, But Clarification On Liability Issue Is Needed
- Johnson & Johnson ( JNJ ) Q2 2023 Earnings Call Transcript
- J&J gets expanded approval for cardiac ablation products
- J&J falls after bankruptcy plan rejected for second time
For further details see:
Johnson & Johnson wins FDA nod for new multiple myeloma therapy